Crimean Congo-haemorrhagic fever treated with oral ribavirin (Q40681314)

22 September 2017

Crimean Congo-haemorrhagic fever treated with oral ribavirin (English)

1 reference

Orthonairovirus haemorrhagiae

22 September 2017

0 references

1 reference

1

S P Fisher-Hoch

1 reference

22 September 2017

J A Khan

2

1 reference

22 September 2017

S Rehman

3

1 reference

22 September 2017

S Mirza

4

1 reference

22 September 2017

M Khurshid

5

1 reference

22 September 2017

J B McCormick

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

22 September 2017

1 reference

22 September 2017

346

1 reference

22 September 2017

8973

1 reference

22 September 2017

472-475

1 reference

Review Article 1: The Epidemiology of Tick-Borne Crimean-Congo Hemorrhagic Fever in Asia, Europe, and Africa23

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Lassa fever. Effective therapy with ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Antibody response in Crimean-Congo hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

A case-control study of the clinical diagnosis and course of Lassa fever

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Treatment of influenza A (H1N1) virus infection with ribavirin aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Effects of ribavirin on red blood cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Risk of human infections with Crimean-Congo hemorrhagic fever virus in a South African rural community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

Risk factors for Crimean-Congo hemorrhagic fever in rural northern Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991323-8

7 January 2021

10.1016/S0140-6736(95)91323-8

Identifiers

DOI

1 reference

22 September 2017

1 reference